nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—hematologic cancer	0.344	1	CbGaD
Moxifloxacin—TOP2A—Idarubicin—hematologic cancer	0.124	0.281	CbGbCtD
Moxifloxacin—TOP2A—Daunorubicin—hematologic cancer	0.0881	0.199	CbGbCtD
Moxifloxacin—TOP2A—Teniposide—hematologic cancer	0.0765	0.173	CbGbCtD
Moxifloxacin—TOP2A—Mitoxantrone—hematologic cancer	0.0535	0.121	CbGbCtD
Moxifloxacin—TOP2A—Epirubicin—hematologic cancer	0.0433	0.0978	CbGbCtD
Moxifloxacin—TOP2A—Etoposide—hematologic cancer	0.0337	0.0762	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—hematologic cancer	0.023	0.052	CbGbCtD
Moxifloxacin—TOP2A—G0 and Early G1—MYBL2—hematologic cancer	0.000995	0.049	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—MYBL2—hematologic cancer	0.000884	0.0435	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—hematologic cancer	0.000601	0.0296	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DCK—hematologic cancer	0.000559	0.0275	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CEBPD—hematologic cancer	0.000558	0.0275	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—H3F3A—hematologic cancer	0.000503	0.0248	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PPP1R13L—hematologic cancer	0.000492	0.0242	CbGpPWpGaD
Moxifloxacin—Enoxacin—TOP2A—hematologic cancer	0.000401	0.162	CrCbGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SMC3—hematologic cancer	0.000383	0.0189	CbGpPWpGaD
Moxifloxacin—Sparfloxacin—TOP2A—hematologic cancer	0.000369	0.149	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PER3—hematologic cancer	0.000358	0.0176	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—CDK2—hematologic cancer	0.000324	0.016	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—hematologic cancer	0.000316	0.0155	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CRY1—hematologic cancer	0.000304	0.015	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CRY2—hematologic cancer	0.000304	0.015	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PER2—hematologic cancer	0.000304	0.015	CbGpPWpGaD
Moxifloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.000304	0.123	CrCbGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—hematologic cancer	0.000263	0.013	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—hematologic cancer	0.000262	0.0129	CbGpPWpGaD
Moxifloxacin—Levofloxacin—TOP2A—hematologic cancer	0.000259	0.105	CrCbGaD
Moxifloxacin—Ofloxacin—TOP2A—hematologic cancer	0.000259	0.105	CrCbGaD
Moxifloxacin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000259	0.0777	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—ID3—hematologic cancer	0.000259	0.0127	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYBL2—hematologic cancer	0.000258	0.0127	CbGpPWpGaD
Moxifloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.000251	0.101	CrCbGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—hematologic cancer	0.000236	0.0116	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PER1—hematologic cancer	0.00023	0.0113	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—KMT2A—hematologic cancer	0.00023	0.0113	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	0.00022	0.0108	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SMC1A—hematologic cancer	0.000213	0.0105	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TOP1—hematologic cancer	0.000211	0.0104	CbGpPWpGaD
Moxifloxacin—Norfloxacin—TOP2A—hematologic cancer	0.00021	0.0852	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—ID2—hematologic cancer	0.000205	0.0101	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—hematologic cancer	0.000196	0.00965	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	0.000196	0.00964	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—hematologic cancer	0.000186	0.00915	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND3—hematologic cancer	0.000185	0.00911	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—hematologic cancer	0.000178	0.00877	CbGpPWpGaD
Moxifloxacin—Gatifloxacin—ALB—hematologic cancer	0.000168	0.0681	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—ARNTL—hematologic cancer	0.000164	0.00808	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	0.000162	0.00798	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—hematologic cancer	0.000152	0.00751	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	0.000145	0.00716	CbGpPWpGaD
Moxifloxacin—TOP2A—Topotecan—Irinotecan—hematologic cancer	0.000143	0.0431	CbGdCrCtD
Moxifloxacin—TOP2A—Etoposide—Teniposide—hematologic cancer	0.000143	0.0429	CbGdCrCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hematologic cancer	0.000141	0.00696	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—JUND—hematologic cancer	0.00014	0.00687	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—hematologic cancer	0.000138	0.00679	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	0.000138	0.00679	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—hematologic cancer	0.000137	0.00675	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—hematologic cancer	0.000134	0.00658	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	0.000131	0.00643	CbGpPWpGaD
Moxifloxacin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	0.000128	0.0386	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—CST3—hematologic cancer	0.000125	0.00617	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	0.000123	0.00605	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—hematologic cancer	0.00012	0.00589	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—hematologic cancer	0.000119	0.00584	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PML—hematologic cancer	0.000118	0.00581	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RAD1—hematologic cancer	0.000117	0.00574	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—hematologic cancer	0.000113	0.00557	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	0.000112	0.00551	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—hematologic cancer	0.00011	0.00541	CbGpPWpGaD
Moxifloxacin—TOP2A—Podofilox—Teniposide—hematologic cancer	0.000109	0.0327	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—TERF2—hematologic cancer	0.000108	0.0053	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	0.000107	0.00526	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—hematologic cancer	0.000106	0.00523	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RAD21—hematologic cancer	0.000106	0.00523	CbGpPWpGaD
Moxifloxacin—Sparfloxacin—ABCB1—hematologic cancer	0.000105	0.0424	CrCbGaD
Moxifloxacin—TOP2A—Vindesine—Vinblastine—hematologic cancer	0.000103	0.0308	CbGdCrCtD
Moxifloxacin—TOP2A—Vindesine—Vincristine—hematologic cancer	0.000103	0.0308	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—EZH2—hematologic cancer	0.000102	0.00505	CbGpPWpGaD
Moxifloxacin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	9.88e-05	0.0297	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—SMC3—hematologic cancer	9.88e-05	0.00487	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—hematologic cancer	9.83e-05	0.00484	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	9.72e-05	0.00479	CbGpPWpGaD
Moxifloxacin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	9.69e-05	0.0291	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	9.69e-05	0.0291	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	9.69e-05	0.0291	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—HDAC2—hematologic cancer	9.68e-05	0.00477	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RAD21—hematologic cancer	9.5e-05	0.00468	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYBL2—hematologic cancer	9.47e-05	0.00466	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	9.04e-05	0.00445	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—SMC3—hematologic cancer	8.83e-05	0.00435	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	8.74e-05	0.0043	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYBL2—hematologic cancer	8.47e-05	0.00417	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—POT1—hematologic cancer	8.47e-05	0.00417	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	8.45e-05	0.00416	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	8.43e-05	0.00415	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—hematologic cancer	8.42e-05	0.00414	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—hematologic cancer	8.38e-05	0.00413	CbGpPWpGaD
Moxifloxacin—TOP2A—Menadione—Thalidomide—hematologic cancer	8.24e-05	0.0248	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	8.13e-05	0.004	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	8.13e-05	0.004	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	8.05e-05	0.00397	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—hematologic cancer	7.95e-05	0.00392	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—ATR—hematologic cancer	7.87e-05	0.00388	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—hematologic cancer	7.87e-05	0.00387	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—STAG2—hematologic cancer	7.85e-05	0.00386	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	7.65e-05	0.00377	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	7.55e-05	0.00372	CbGpPWpGaD
Moxifloxacin—TOP2A—Cladribine—Pentostatin—hematologic cancer	7.48e-05	0.0225	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	7.44e-05	0.00367	CbGpPWpGaD
Moxifloxacin—Levofloxacin—ABCB1—hematologic cancer	7.38e-05	0.0299	CrCbGaD
Moxifloxacin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	7.34e-05	0.0221	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	7.34e-05	0.0221	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	7.34e-05	0.0221	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—NCOR1—hematologic cancer	7.33e-05	0.00361	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	7.32e-05	0.0036	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	7.3e-05	0.00359	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—hematologic cancer	7.18e-05	0.00353	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—H3F3B—hematologic cancer	7.18e-05	0.00353	CbGpPWpGaD
Moxifloxacin—Ciprofloxacin—ABCB1—hematologic cancer	7.13e-05	0.0288	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	7.1e-05	0.0035	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	7.06e-05	0.00348	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—STAG2—hematologic cancer	7.02e-05	0.00346	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PRKCG—hematologic cancer	7e-05	0.00345	CbGpPWpGaD
Moxifloxacin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	6.92e-05	0.0208	CbGdCrCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—hematologic cancer	6.92e-05	0.00341	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	6.85e-05	0.00337	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND3—hematologic cancer	6.79e-05	0.00334	CbGpPWpGaD
Moxifloxacin—TOP2A—Cladribine—Clofarabine—hematologic cancer	6.67e-05	0.0201	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—FAS—hematologic cancer	6.57e-05	0.00324	CbGpPWpGaD
Moxifloxacin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	6.47e-05	0.0195	CbGdCrCtD
Moxifloxacin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	6.47e-05	0.0195	CbGdCrCtD
Moxifloxacin—TOP2A—Teniposide—Etoposide—hematologic cancer	6.47e-05	0.0194	CbGdCrCtD
Moxifloxacin—TOP2A—Podofilox—Etoposide—hematologic cancer	6.47e-05	0.0194	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—NUP98—hematologic cancer	6.46e-05	0.00318	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—FOXM1—hematologic cancer	6.42e-05	0.00316	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—H3F3B—hematologic cancer	6.42e-05	0.00316	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	6.38e-05	0.00314	CbGpPWpGaD
Moxifloxacin—TOP2A—Cladribine—Nelarabine—hematologic cancer	6.27e-05	0.0189	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—NUP214—hematologic cancer	6.23e-05	0.00307	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—NPM1—hematologic cancer	6.18e-05	0.00304	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	6.12e-05	0.00301	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	6.08e-05	0.00299	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND3—hematologic cancer	6.07e-05	0.00299	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	6.05e-05	0.00298	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	6.03e-05	0.00297	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	6e-05	0.00295	CbGpPWpGaD
Moxifloxacin—TOP2A—Floxuridine—Cladribine—hematologic cancer	5.95e-05	0.0179	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	5.86e-05	0.00288	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	5.86e-05	0.00288	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	5.86e-05	0.00288	CbGpPWpGaD
Moxifloxacin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	5.8e-05	0.0174	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—CDK4—hematologic cancer	5.79e-05	0.00285	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—NUP98—hematologic cancer	5.78e-05	0.00285	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—NUP214—hematologic cancer	5.57e-05	0.00274	CbGpPWpGaD
Moxifloxacin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	5.57e-05	0.0167	CbGdCrCtD
Moxifloxacin—TOP2A—Vincristine—Vinblastine—hematologic cancer	5.53e-05	0.0166	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—SMC1A—hematologic cancer	5.5e-05	0.00271	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	5.4e-05	0.00266	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—H3F3A—hematologic cancer	5.39e-05	0.00265	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	5.38e-05	0.00265	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	5.28e-05	0.0026	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	5.26e-05	0.00259	CbGpPWpGaD
Moxifloxacin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	5.25e-05	0.0158	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—CREB1—hematologic cancer	5.18e-05	0.00255	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—hematologic cancer	5.14e-05	0.00253	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MLH1—hematologic cancer	5.13e-05	0.00253	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—hematologic cancer	5.06e-05	0.00249	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	5.02e-05	0.00247	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	4.97e-05	0.00245	CbGpPWpGaD
Moxifloxacin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	4.93e-05	0.0148	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—SMC1A—hematologic cancer	4.91e-05	0.00242	CbGpPWpGaD
Moxifloxacin—TOP2A—Cladribine—Fludarabine—hematologic cancer	4.9e-05	0.0147	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—H3F3A—hematologic cancer	4.82e-05	0.00237	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	4.81e-05	0.00237	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	4.77e-05	0.00235	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	4.54e-05	0.00223	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	4.53e-05	0.00223	CbGpPWpGaD
Moxifloxacin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	4.53e-05	0.0136	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—CDK6—hematologic cancer	4.52e-05	0.00223	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	4.47e-05	0.0022	CbGpPWpGaD
Moxifloxacin—TOP2A—Vinblastine—Vincristine—hematologic cancer	4.45e-05	0.0134	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—hematologic cancer	4.35e-05	0.00214	CbGpPWpGaD
Moxifloxacin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	4.27e-05	0.0129	CbGdCrCtD
Moxifloxacin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	4.22e-05	0.0127	CbGdCrCtD
Moxifloxacin—TOP2A—Clofarabine—Cladribine—hematologic cancer	4.17e-05	0.0125	CbGdCrCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—hematologic cancer	4.12e-05	0.00203	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	4.08e-05	0.00201	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—HSP90AA1—hematologic cancer	4.06e-05	0.002	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	4e-05	0.00197	CbGpPWpGaD
Moxifloxacin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	3.96e-05	0.0119	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	3.9e-05	0.00192	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	3.89e-05	0.00192	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND2—hematologic cancer	3.89e-05	0.00191	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	3.88e-05	0.00191	CbGpPWpGaD
Moxifloxacin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	3.85e-05	0.0116	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.76e-05	0.00185	CbGpPWpGaD
Moxifloxacin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	3.76e-05	0.0113	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.76e-05	0.00185	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—JUN—hematologic cancer	3.73e-05	0.00184	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	3.67e-05	0.00181	CbGpPWpGaD
Moxifloxacin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	3.64e-05	0.0109	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—PTEN—hematologic cancer	3.61e-05	0.00178	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.58e-05	0.00176	CbGpPWpGaD
Moxifloxacin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	3.54e-05	0.0106	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—MAPK8—hematologic cancer	3.53e-05	0.00174	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2B—hematologic cancer	3.49e-05	0.00172	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.48e-05	0.00172	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EP300—hematologic cancer	3.44e-05	0.00169	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.39e-05	0.00167	CbGpPWpGaD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	3.37e-05	0.0101	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	3.37e-05	0.0101	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	3.37e-05	0.0101	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—hematologic cancer	3.36e-05	0.00166	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.21e-05	0.00158	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.12e-05	0.00154	CbGpPWpGaD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	3.12e-05	0.00938	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	3.12e-05	0.00938	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	3.12e-05	0.00938	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.11e-05	0.00153	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—hematologic cancer	3.09e-05	0.00152	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—BIRC5—hematologic cancer	3.01e-05	0.00148	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—hematologic cancer	2.92e-05	0.00144	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TERT—hematologic cancer	2.91e-05	0.00144	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.91e-05	0.00143	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.88e-05	0.00142	CbGpPWpGaD
Moxifloxacin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	2.76e-05	0.0083	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—CDK2—hematologic cancer	2.76e-05	0.00136	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.65e-05	0.0013	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—ATM—hematologic cancer	2.62e-05	0.00129	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK4—hematologic cancer	2.61e-05	0.00128	CbGpPWpGaD
Moxifloxacin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	2.61e-05	0.00784	CbGdCrCtD
Moxifloxacin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	2.61e-05	0.00784	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.56e-05	0.00126	CbGpPWpGaD
Moxifloxacin—TOP2A—Azacitidine—Cladribine—hematologic cancer	2.54e-05	0.00764	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	2.54e-05	0.00125	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	2.46e-05	0.00121	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RB1—hematologic cancer	2.27e-05	0.00112	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	2.25e-05	0.00111	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	2.23e-05	0.0011	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.16e-05	0.00107	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	1.99e-05	0.000982	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	1.97e-05	0.000972	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MDM2—hematologic cancer	1.93e-05	0.000952	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.88e-05	0.000928	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.82e-05	0.000897	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	1.77e-05	0.000869	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	1.73e-05	0.000854	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—hematologic cancer	1.68e-05	0.000829	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	1.63e-05	0.000802	CbGpPWpGaD
Moxifloxacin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.56e-05	0.00468	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.55e-05	0.000765	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—EP300—hematologic cancer	1.55e-05	0.000763	CbGpPWpGaD
Moxifloxacin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.52e-05	0.00457	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	1.51e-05	0.000744	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	1.39e-05	0.000684	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYC—hematologic cancer	1.35e-05	0.000665	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TP53—hematologic cancer	1.11e-05	0.000546	CbGpPWpGaD
Moxifloxacin—Anaemia—Methotrexate—hematologic cancer	7.97e-06	4.26e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Dexamethasone—hematologic cancer	7.96e-06	4.26e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Betamethasone—hematologic cancer	7.96e-06	4.26e-05	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—hematologic cancer	7.96e-06	4.26e-05	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—hematologic cancer	7.95e-06	4.25e-05	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—hematologic cancer	7.92e-06	4.24e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	7.9e-06	4.23e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.9e-06	4.23e-05	CcSEcCtD
Moxifloxacin—Dysgeusia—Epirubicin—hematologic cancer	7.9e-06	4.23e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Triamcinolone—hematologic cancer	7.85e-06	4.2e-05	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—hematologic cancer	7.83e-06	4.19e-05	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—hematologic cancer	7.8e-06	4.17e-05	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—hematologic cancer	7.78e-06	4.16e-05	CcSEcCtD
Moxifloxacin—Malaise—Methotrexate—hematologic cancer	7.77e-06	4.16e-05	CcSEcCtD
Moxifloxacin—Dizziness—Etoposide—hematologic cancer	7.77e-06	4.16e-05	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—hematologic cancer	7.76e-06	4.15e-05	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—hematologic cancer	7.74e-06	4.14e-05	CcSEcCtD
Moxifloxacin—Vertigo—Methotrexate—hematologic cancer	7.74e-06	4.14e-05	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—hematologic cancer	7.73e-06	4.13e-05	CcSEcCtD
Moxifloxacin—Leukopenia—Methotrexate—hematologic cancer	7.72e-06	4.13e-05	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—hematologic cancer	7.69e-06	4.12e-05	CcSEcCtD
Moxifloxacin—Urticaria—Dexamethasone—hematologic cancer	7.68e-06	4.11e-05	CcSEcCtD
Moxifloxacin—Urticaria—Betamethasone—hematologic cancer	7.68e-06	4.11e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.67e-06	4.1e-05	CcSEcCtD
Moxifloxacin—Dizziness—Prednisolone—hematologic cancer	7.66e-06	4.1e-05	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—hematologic cancer	7.66e-06	4.1e-05	CcSEcCtD
Moxifloxacin—Asthenia—Triamcinolone—hematologic cancer	7.64e-06	4.09e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Dexamethasone—hematologic cancer	7.64e-06	4.09e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Dexamethasone—hematologic cancer	7.64e-06	4.09e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Betamethasone—hematologic cancer	7.64e-06	4.09e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Betamethasone—hematologic cancer	7.64e-06	4.09e-05	CcSEcCtD
Moxifloxacin—Nausea—Cisplatin—hematologic cancer	7.61e-06	4.07e-05	CcSEcCtD
Moxifloxacin—Insomnia—Prednisone—hematologic cancer	7.61e-06	4.07e-05	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—hematologic cancer	7.6e-06	4.07e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Prednisone—hematologic cancer	7.56e-06	4.04e-05	CcSEcCtD
Moxifloxacin—Pruritus—Triamcinolone—hematologic cancer	7.54e-06	4.03e-05	CcSEcCtD
Moxifloxacin—Cough—Methotrexate—hematologic cancer	7.52e-06	4.02e-05	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—hematologic cancer	7.51e-06	4.02e-05	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Epirubicin—hematologic cancer	7.48e-06	4e-05	CcSEcCtD
Moxifloxacin—Convulsion—Methotrexate—hematologic cancer	7.47e-06	4e-05	CcSEcCtD
Moxifloxacin—Vomiting—Etoposide—hematologic cancer	7.47e-06	4e-05	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—hematologic cancer	7.46e-06	3.99e-05	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—hematologic cancer	7.46e-06	3.99e-05	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—hematologic cancer	7.46e-06	3.99e-05	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—hematologic cancer	7.41e-06	3.97e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Prednisone—hematologic cancer	7.41e-06	3.96e-05	CcSEcCtD
Moxifloxacin—Rash—Etoposide—hematologic cancer	7.4e-06	3.96e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Etoposide—hematologic cancer	7.4e-06	3.96e-05	CcSEcCtD
Moxifloxacin—Headache—Etoposide—hematologic cancer	7.36e-06	3.94e-05	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—hematologic cancer	7.35e-06	3.93e-05	CcSEcCtD
Moxifloxacin—Myalgia—Methotrexate—hematologic cancer	7.34e-06	3.93e-05	CcSEcCtD
Moxifloxacin—Chest pain—Methotrexate—hematologic cancer	7.34e-06	3.93e-05	CcSEcCtD
Moxifloxacin—Arthralgia—Methotrexate—hematologic cancer	7.34e-06	3.93e-05	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—hematologic cancer	7.32e-06	3.92e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Prednisone—hematologic cancer	7.32e-06	3.91e-05	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—hematologic cancer	7.31e-06	3.91e-05	CcSEcCtD
Moxifloxacin—Rash—Prednisolone—hematologic cancer	7.3e-06	3.91e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Prednisolone—hematologic cancer	7.3e-06	3.9e-05	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.29e-06	3.9e-05	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—hematologic cancer	7.27e-06	3.89e-05	CcSEcCtD
Moxifloxacin—Fatigue—Prednisone—hematologic cancer	7.26e-06	3.88e-05	CcSEcCtD
Moxifloxacin—Headache—Prednisolone—hematologic cancer	7.26e-06	3.88e-05	CcSEcCtD
Moxifloxacin—Discomfort—Methotrexate—hematologic cancer	7.25e-06	3.88e-05	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—hematologic cancer	7.25e-06	3.88e-05	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—hematologic cancer	7.25e-06	3.88e-05	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—hematologic cancer	7.23e-06	3.87e-05	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—hematologic cancer	7.22e-06	3.86e-05	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—hematologic cancer	7.22e-06	3.86e-05	CcSEcCtD
Moxifloxacin—Constipation—Prednisone—hematologic cancer	7.2e-06	3.85e-05	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—hematologic cancer	7.18e-06	3.84e-05	CcSEcCtD
Moxifloxacin—Palpitations—Epirubicin—hematologic cancer	7.13e-06	3.81e-05	CcSEcCtD
Moxifloxacin—Confusional state—Methotrexate—hematologic cancer	7.09e-06	3.8e-05	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—hematologic cancer	7.09e-06	3.79e-05	CcSEcCtD
Moxifloxacin—Dizziness—Triamcinolone—hematologic cancer	7.04e-06	3.77e-05	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—hematologic cancer	7.04e-06	3.77e-05	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	7.03e-06	3.76e-05	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—hematologic cancer	7.03e-06	3.76e-05	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—hematologic cancer	6.99e-06	3.74e-05	CcSEcCtD
Moxifloxacin—Nausea—Etoposide—hematologic cancer	6.98e-06	3.73e-05	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—hematologic cancer	6.96e-06	3.73e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Prednisone—hematologic cancer	6.94e-06	3.71e-05	CcSEcCtD
Moxifloxacin—Asthenia—Dexamethasone—hematologic cancer	6.93e-06	3.71e-05	CcSEcCtD
Moxifloxacin—Asthenia—Betamethasone—hematologic cancer	6.93e-06	3.71e-05	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—hematologic cancer	6.92e-06	3.71e-05	CcSEcCtD
Moxifloxacin—Nervous system disorder—Methotrexate—hematologic cancer	6.9e-06	3.69e-05	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—hematologic cancer	6.9e-06	3.69e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	6.89e-06	3.69e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	6.88e-06	3.68e-05	CcSEcCtD
Moxifloxacin—Nausea—Prednisolone—hematologic cancer	6.88e-06	3.68e-05	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—hematologic cancer	6.87e-06	3.67e-05	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—hematologic cancer	6.87e-06	3.67e-05	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—hematologic cancer	6.87e-06	3.67e-05	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—hematologic cancer	6.86e-06	3.67e-05	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—hematologic cancer	6.84e-06	3.66e-05	CcSEcCtD
Moxifloxacin—Pruritus—Dexamethasone—hematologic cancer	6.84e-06	3.66e-05	CcSEcCtD
Moxifloxacin—Pruritus—Betamethasone—hematologic cancer	6.84e-06	3.66e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Methotrexate—hematologic cancer	6.83e-06	3.66e-05	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.82e-06	3.65e-05	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	6.8e-06	3.64e-05	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—hematologic cancer	6.79e-06	3.63e-05	CcSEcCtD
Moxifloxacin—Vomiting—Triamcinolone—hematologic cancer	6.77e-06	3.62e-05	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—hematologic cancer	6.73e-06	3.6e-05	CcSEcCtD
Moxifloxacin—Rash—Triamcinolone—hematologic cancer	6.72e-06	3.59e-05	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—hematologic cancer	6.72e-06	3.59e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Triamcinolone—hematologic cancer	6.71e-06	3.59e-05	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—hematologic cancer	6.71e-06	3.59e-05	CcSEcCtD
Moxifloxacin—Anorexia—Methotrexate—hematologic cancer	6.71e-06	3.59e-05	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—hematologic cancer	6.69e-06	3.58e-05	CcSEcCtD
Moxifloxacin—Urticaria—Prednisone—hematologic cancer	6.69e-06	3.58e-05	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—hematologic cancer	6.68e-06	3.57e-05	CcSEcCtD
Moxifloxacin—Headache—Triamcinolone—hematologic cancer	6.67e-06	3.57e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Prednisone—hematologic cancer	6.65e-06	3.56e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Prednisone—hematologic cancer	6.65e-06	3.56e-05	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—hematologic cancer	6.64e-06	3.55e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Dexamethasone—hematologic cancer	6.61e-06	3.54e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Betamethasone—hematologic cancer	6.61e-06	3.54e-05	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—hematologic cancer	6.6e-06	3.53e-05	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—hematologic cancer	6.58e-06	3.52e-05	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	6.58e-06	3.52e-05	CcSEcCtD
Moxifloxacin—Hypotension—Methotrexate—hematologic cancer	6.57e-06	3.52e-05	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—hematologic cancer	6.56e-06	3.51e-05	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—hematologic cancer	6.51e-06	3.48e-05	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—hematologic cancer	6.48e-06	3.47e-05	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—hematologic cancer	6.47e-06	3.46e-05	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—hematologic cancer	6.46e-06	3.45e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	6.45e-06	3.45e-05	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—hematologic cancer	6.44e-06	3.45e-05	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—hematologic cancer	6.43e-06	3.44e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.41e-06	3.43e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—hematologic cancer	6.39e-06	3.42e-05	CcSEcCtD
Moxifloxacin—Dizziness—Dexamethasone—hematologic cancer	6.39e-06	3.42e-05	CcSEcCtD
Moxifloxacin—Dizziness—Betamethasone—hematologic cancer	6.39e-06	3.42e-05	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	6.36e-06	3.41e-05	CcSEcCtD
Moxifloxacin—Insomnia—Methotrexate—hematologic cancer	6.36e-06	3.4e-05	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—hematologic cancer	6.35e-06	3.4e-05	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—hematologic cancer	6.35e-06	3.4e-05	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—hematologic cancer	6.35e-06	3.4e-05	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—hematologic cancer	6.33e-06	3.39e-05	CcSEcCtD
Moxifloxacin—Nausea—Triamcinolone—hematologic cancer	6.33e-06	3.39e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Methotrexate—hematologic cancer	6.32e-06	3.38e-05	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.31e-06	3.38e-05	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—hematologic cancer	6.28e-06	3.36e-05	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—hematologic cancer	6.28e-06	3.36e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Methotrexate—hematologic cancer	6.27e-06	3.36e-05	CcSEcCtD
Moxifloxacin—Somnolence—Methotrexate—hematologic cancer	6.25e-06	3.35e-05	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—hematologic cancer	6.21e-06	3.32e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Prednisone—hematologic cancer	6.2e-06	3.32e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Methotrexate—hematologic cancer	6.19e-06	3.31e-05	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—hematologic cancer	6.15e-06	3.29e-05	CcSEcCtD
Moxifloxacin—Vomiting—Dexamethasone—hematologic cancer	6.15e-06	3.29e-05	CcSEcCtD
Moxifloxacin—Vomiting—Betamethasone—hematologic cancer	6.15e-06	3.29e-05	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—hematologic cancer	6.14e-06	3.29e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Methotrexate—hematologic cancer	6.12e-06	3.27e-05	CcSEcCtD
Moxifloxacin—Rash—Betamethasone—hematologic cancer	6.09e-06	3.26e-05	CcSEcCtD
Moxifloxacin—Rash—Dexamethasone—hematologic cancer	6.09e-06	3.26e-05	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—hematologic cancer	6.09e-06	3.26e-05	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	6.09e-06	3.26e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Betamethasone—hematologic cancer	6.09e-06	3.26e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Dexamethasone—hematologic cancer	6.09e-06	3.26e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.07e-06	3.25e-05	CcSEcCtD
Moxifloxacin—Fatigue—Methotrexate—hematologic cancer	6.06e-06	3.24e-05	CcSEcCtD
Moxifloxacin—Headache—Dexamethasone—hematologic cancer	6.06e-06	3.24e-05	CcSEcCtD
Moxifloxacin—Headache—Betamethasone—hematologic cancer	6.06e-06	3.24e-05	CcSEcCtD
Moxifloxacin—Asthenia—Prednisone—hematologic cancer	6.04e-06	3.23e-05	CcSEcCtD
Moxifloxacin—Pain—Methotrexate—hematologic cancer	6.02e-06	3.22e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6e-06	3.21e-05	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—hematologic cancer	5.99e-06	3.21e-05	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—hematologic cancer	5.97e-06	3.2e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	5.96e-06	3.19e-05	CcSEcCtD
Moxifloxacin—Pruritus—Prednisone—hematologic cancer	5.96e-06	3.19e-05	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—hematologic cancer	5.95e-06	3.19e-05	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—hematologic cancer	5.94e-06	3.18e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—hematologic cancer	5.92e-06	3.17e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—hematologic cancer	5.91e-06	3.16e-05	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	5.89e-06	3.15e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Epirubicin—hematologic cancer	5.87e-06	3.14e-05	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—hematologic cancer	5.85e-06	3.13e-05	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—hematologic cancer	5.81e-06	3.11e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Methotrexate—hematologic cancer	5.8e-06	3.1e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—hematologic cancer	5.79e-06	3.1e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Prednisone—hematologic cancer	5.76e-06	3.08e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	5.75e-06	3.08e-05	CcSEcCtD
Moxifloxacin—Nausea—Dexamethasone—hematologic cancer	5.74e-06	3.07e-05	CcSEcCtD
Moxifloxacin—Nausea—Betamethasone—hematologic cancer	5.74e-06	3.07e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—hematologic cancer	5.72e-06	3.06e-05	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—hematologic cancer	5.69e-06	3.05e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.68e-06	3.04e-05	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—hematologic cancer	5.68e-06	3.04e-05	CcSEcCtD
Moxifloxacin—Constipation—Epirubicin—hematologic cancer	5.63e-06	3.01e-05	CcSEcCtD
Moxifloxacin—Pain—Epirubicin—hematologic cancer	5.63e-06	3.01e-05	CcSEcCtD
Moxifloxacin—Urticaria—Methotrexate—hematologic cancer	5.59e-06	2.99e-05	CcSEcCtD
Moxifloxacin—Dizziness—Prednisone—hematologic cancer	5.57e-06	2.98e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Methotrexate—hematologic cancer	5.56e-06	2.98e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Methotrexate—hematologic cancer	5.56e-06	2.98e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.55e-06	2.97e-05	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—hematologic cancer	5.51e-06	2.95e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—hematologic cancer	5.47e-06	2.93e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—hematologic cancer	5.43e-06	2.91e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—hematologic cancer	5.42e-06	2.9e-05	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—hematologic cancer	5.42e-06	2.9e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	5.38e-06	2.88e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—hematologic cancer	5.36e-06	2.87e-05	CcSEcCtD
Moxifloxacin—Vomiting—Prednisone—hematologic cancer	5.35e-06	2.86e-05	CcSEcCtD
Moxifloxacin—Rash—Prednisone—hematologic cancer	5.31e-06	2.84e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Prednisone—hematologic cancer	5.3e-06	2.84e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—hematologic cancer	5.3e-06	2.83e-05	CcSEcCtD
Moxifloxacin—Headache—Prednisone—hematologic cancer	5.27e-06	2.82e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.26e-06	2.81e-05	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—hematologic cancer	5.25e-06	2.81e-05	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—hematologic cancer	5.23e-06	2.8e-05	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—hematologic cancer	5.21e-06	2.79e-05	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—hematologic cancer	5.21e-06	2.79e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—hematologic cancer	5.2e-06	2.78e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—hematologic cancer	5.2e-06	2.78e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Methotrexate—hematologic cancer	5.18e-06	2.77e-05	CcSEcCtD
Moxifloxacin—Asthenia—Methotrexate—hematologic cancer	5.05e-06	2.7e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—hematologic cancer	5.02e-06	2.69e-05	CcSEcCtD
Moxifloxacin—Nausea—Prednisone—hematologic cancer	5e-06	2.68e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.98e-06	2.67e-05	CcSEcCtD
Moxifloxacin—Pruritus—Methotrexate—hematologic cancer	4.98e-06	2.66e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—hematologic cancer	4.85e-06	2.6e-05	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—hematologic cancer	4.84e-06	2.59e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—hematologic cancer	4.82e-06	2.58e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—hematologic cancer	4.82e-06	2.58e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Methotrexate—hematologic cancer	4.81e-06	2.58e-05	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—hematologic cancer	4.72e-06	2.53e-05	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—hematologic cancer	4.66e-06	2.49e-05	CcSEcCtD
Moxifloxacin—Dizziness—Methotrexate—hematologic cancer	4.65e-06	2.49e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Epirubicin—hematologic cancer	4.5e-06	2.41e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—hematologic cancer	4.49e-06	2.4e-05	CcSEcCtD
Moxifloxacin—Vomiting—Methotrexate—hematologic cancer	4.47e-06	2.39e-05	CcSEcCtD
Moxifloxacin—Rash—Methotrexate—hematologic cancer	4.44e-06	2.37e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Methotrexate—hematologic cancer	4.43e-06	2.37e-05	CcSEcCtD
Moxifloxacin—Headache—Methotrexate—hematologic cancer	4.41e-06	2.36e-05	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—hematologic cancer	4.37e-06	2.34e-05	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—hematologic cancer	4.35e-06	2.33e-05	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—hematologic cancer	4.31e-06	2.31e-05	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—hematologic cancer	4.19e-06	2.24e-05	CcSEcCtD
Moxifloxacin—Nausea—Methotrexate—hematologic cancer	4.18e-06	2.24e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—hematologic cancer	4.17e-06	2.23e-05	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—hematologic cancer	4.15e-06	2.22e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—hematologic cancer	4.15e-06	2.22e-05	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—hematologic cancer	4.12e-06	2.21e-05	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—hematologic cancer	4.03e-06	2.16e-05	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—hematologic cancer	3.91e-06	2.09e-05	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—hematologic cancer	3.87e-06	2.07e-05	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—hematologic cancer	3.84e-06	2.05e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—hematologic cancer	3.84e-06	2.05e-05	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—hematologic cancer	3.82e-06	2.04e-05	CcSEcCtD
Moxifloxacin—Nausea—Doxorubicin—hematologic cancer	3.62e-06	1.94e-05	CcSEcCtD
